Continuous versus Intermittent Monitoring of Ventricular Rate in Patients with Permanent Atrial Fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 5, 2012, Pages 598-604

  Ziegler, Paul D ^a   Koehler, Jodi L ^a   Verma, Atul ^b  

^a MEDTRONIC INC   (United States)

^b SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

Author keywords

atrial fibrillation; congestive heart failure; databases

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR PROCEDURE; CONTINUOUS MONITORING; DEFIBRILLATOR; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERMETHOD COMPARISON; INTERMITTENT MONITORING; MAJOR CLINICAL STUDY; MALE; MONITORING; PREVALENCE; RETROSPECTIVE STUDY; VENTRICULAR RATE CONTROL;

AGED; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MINNESOTA; PREVALENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84860840963     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03349.x     Document Type: Article

References (31)

1. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, et al,. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125.
2. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, et al,. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
3. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, et al,. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358: 2667-2677.
4. Marshall DA, Levy AR, Vidaillet H, Fenwick E, Slee A, Blackhouse G, Greene HL, et al,. Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med 2004; 141: 653-661.
5. Hilliard AA, Miller TD, Hodge DO, Gibbons RJ,. Heart rate control in patients with atrial fibrillation referred for exercise testing. Am J Cardiol 2008; 102: 704-708.
6. Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Hillege HL, et al,. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010; 362: 1363-1373.
7. Willems R, Morck ML, Exner DV, Rose SM, Gillis AM,. Ventricular high-rate episodes in pacemaker diagnostics identify a high-risk subgroup of patients with tachy-brady syndrome. Heart Rhythm 2004; 1: 414-421.
8. Knight BP, Desai A, Coman J, Faddis M, Yong P,. Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol 2004; 44: 72-77.
9. Boriani G, Gasparini M, Landolina M, Lunati M, Proclemer A, Lonardi G, Iacopino S, et al,. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy. Eur J Heart Fail 2011; 13: 868-876.
10. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, et al,. Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet 2010; 376: 875-885.
11. Böhm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, et al,. Heart rate as a risk factor in chronic heart failure (SHIFT): The association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 2010; 376: 886-894.
12. Okin PM, Kjeldsen SE, Julius S, Hille DA, Dahlöf B, Edelman JM, Devereux RB,. All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy. Eur Heart J 2010; 31: 2271-2279.
13. Strickberger SA, Ip J, Saksena S, Curry K, Bahnson TD, Ziegler PD,. Relationship between atrial tachycardias and symptoms. Heart Rhythm 2005; 2: 125-131.
14. Ziegler PD, Koehler JL, Mehra R,. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm 2006; 3: 1445-1452.
15. Schoels W, Swerdlow CD, Jung W, Stein KM, Seidl K, Haffajee CJ,. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system. J Cardiovasc Electrophysiol 2001; 12: 521-528.
16. Israel CW, Hügl B, Unterberg C, Lawo T, Kennis I, Hettrick D, Hohnloser SH,. Pace-termination and pacing for prevention of atrial tachyarrhythmias: Results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001; 12: 1121-1128.
17. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, et al,. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 123: e269-e367.
18. Gillis AM, Verma A, Talajic M, Nattel S, Dorian P,. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: Rate and rhythm management. Can J Cardiol 2011; 27: 47-59.
19. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, et al,. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
20. Olshansky B, Rosenfeld LE, Warner AL, Solomon AJ, O'Neill G, Sharma A, Platia E, et al,. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: Approaches to control rate in atrial fibrillation. J Am Coll Cardiol 2004; 43: 1201-1208.
21. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, et al,. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840.
22. Fischer A, Ousdigian KT, Johnson JW, Gillberg JM, Wilkoff BL,. The impact of AF with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients. Heart Rhythm 2011 (in press).
23. Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ,. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009; 360: 668-678.
24. Reddy VY, Neuzil P, d'Avila A, Laragy M, Malchano ZJ, Kralovec S, Kim SJ, et al,. Balloon catheter ablation to treat paroxysmal atrial fibrillation: What is the level of pulmonary venous isolation? Heart Rhythm 2008; 5: 353-360.
25. Sarkar S, Ritscher D, Mehra R,. A detector for a chronic implantable atrial tachyarrhythmia monitor. IEEE Trans Biomed Eng 2008; 55: 1219-1224.
26. Hindricks G, Pokushalov E, Urban L, Taborsky M, Kuck KH, Lebedev D, Rieger G, et al,. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial. Circ Arrhythm Electrophysiol 2010; 3: 141-147.
27. Vasamreddy CR, Dalal D, Dong J, Cheng A, Spragg D, Lamiy SZ, Meininger G, et al,. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2006; 17: 134-139.
28. Sarkar S, Koehler J, Crossley GH, Tang WHW, Abraham WT, Whellan DJ,. Burden of atrial fibrillation and poor rate control detected by continuous monitoring via implanted devices identifies when a patient is at risk for heart failure hospitalization. (abstract) J Am Coll Cardiol 2011; 57: E107.
29. Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, et al,. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: Results from PARTNERS HF study. J Am Coll Cardiol 2010; 55: 1803-1810.
30. Davy JM, Herold M, Hoglund C, Timmermans A, Alings A, Radzik D, Van Kempen L,. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The efficacy and safety of dronedarone for the control of ventricular rate during atrial fibrillation (ERATO) study. Am Heart J 2008; 156: 527.
31. Le Heuzey JY, De Ferrari GM, Radzik D, Santini M, Zhu J, Davy JM,. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: The DIONYSOS study. J Cardiovasc Electrophysiol 2010; 21: 597-605.